Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis

Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis


However, both drugmakers also have reasons to remain optimistic about the future. Which of these two beaten-down healthcare stocks is the better pick for long-term investors? Here's how Regeneron and Novartis stack up against each other.



from Biotech News